Phase I trial of ESN 364 in volunteers.

Trial Profile

Phase I trial of ESN 364 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2015

At a glance

  • Drugs Fezolinetant (Primary)
  • Indications Endometriosis; Polycystic ovary syndrome; Uterine leiomyoma
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 14 Dec 2015 Results published in the Journal of Clinical Endocrinology and Metabolism
    • 08 Dec 2014 Results published in a Euroscreen media release.
    • 18 Dec 2013 Status changed from planning to recruiting, as reported by a Euroscreen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top